Related Experiment Videos
A proposal to use CA-125 to evaluate activity of new antineoplastic agents in ovarian cancer
Gynecologic Oncology
|December 1, 1993
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Apical hypertrophic cardiomyopathy: A case series at a Brazilian referral center with a maximal follow-up of 15 years.
Annales de cardiologie et d'angeiologie·2021
Platinum-Gemcitabine-Avastin (PGA) for platinum-resistant/refractory ovarian cancer.
European journal of gynaecological oncology·2018
Intravenous vitamin C in the supportive care of cancer patients: a review and rational approach.
Current oncology (Toronto, Ont.)·2018
Surgical intervention in relapsed ovarian cancer is beneficial: contra.
Annals of oncology : official journal of the European Society for Medical Oncology·2013
The use of bevacizumab in the management of ovarian cancer: an argument for single-agent rather than combination therapy.
Annals of oncology : official journal of the European Society for Medical Oncology·2011
Incidence and clinical impact of venous thromboembolism during immunotherapy for gynecologic cancer.
Gynecologic oncology·2026
Low-grade serous ovarian cancer: 2026 expert consensus report.
Gynecologic oncology·2026
Redox shielding unlocks damage-free photopolymerization for GelMA 3D co-cultures mimicking pancreatic tumor complexity.
Biomaterials and biosystems·2026
HMGA2 Expression in Pancreatic Ductal Adenocarcinoma Controls Tumor Microenvironment and Immunosuppression via IL1α.
bioRxiv : the preprint server for biology·2026